potassium chloride 0.3% w/v & glucose 5% w/v solution for infusion
fresenius kabi limited - potassium chloride; glucose monohydrate - solution for infusion - 0.3 + 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates - blood substitutes and perfusion solutions; electrolytes with carbohydrates - prevention and treatment of potassium depletion and/or hypokalaemia in cases where supply of water and carbohydrates is required due to either restriction of the intake of fluids and electrolytes or depletion by normal routes.
tramadol-m solution for injection
"kpe" zdorovye narodu" llc - tramadol (tramadol hydrochloride) - solution for injection - 50mg/ml
roundup® turbo
bayer ag - glyphosate (glycine) 450 g a.e./l; (contains 551 g potassium salt of glyphosate/l)
actifed
pfizer consumer healthcare div. of pfizer new zealand ltd - pseudoephedrine hydrochloride 6 mg/ml; triprolidine hydrochloride monohydrate 0.25 mg/ml (+ 10% manufacturers overage.) - syrup - active: pseudoephedrine hydrochloride 6 mg/ml triprolidine hydrochloride monohydrate 0.25 mg/ml (+ 10% manufacturers overage.) excipient: essence of pineapple 10.05080 glycerol methyl hydroxybenzoate quinoline yellow sodium benzoate sodium hydroxide sucrose sunset yellow fcf water for injection
dbl™ aminophylline injection
pfizer new zealand limited - theophylline hydrate 20.63 mg/ml (as 25mg/ml of aminophylline) - solution for injection - 250 mg/10ml - active: theophylline hydrate 20.63 mg/ml (as 25mg/ml of aminophylline) excipient: edamine as 25mg/ml of aminophylline + extra q.s. to adjust ph (limit nmt 295 mg / g of theophylline) water for injection - dbl™aminophylline injection is indicated for the treatment of reversible bronchospasm associated with chronic bronchitis, emphysema, bronchial asthma and chronic obstructive pulmonary disease. it may also be used for paroxysmal dyspnoea associated with left heart failure
at-eze
douglas pharmaceuticals limited - oxymetazoline hydrochloride 0.25 mg/ml - nasal spray solution - 0.02% w/v - active: oxymetazoline hydrochloride 0.25 mg/ml excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate monohydrate disodium edetate dihydrate purified water as required sodium chloride
at-eze
douglas pharmaceuticals limited - oxymetazoline hydrochloride 0.5 mg/ml - nasal spray solution - 0.05% w/v - active: oxymetazoline hydrochloride 0.5 mg/ml excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate disodium edetate dihydrate purified water as required sodium chloride
cafergot
aft pharmaceuticals ltd - caffeine 100mg (anhydrous); ergotamine tartrate 1mg; ; - tablet - 100 mg/1 mg - active: caffeine 100mg (anhydrous) ergotamine tartrate 1mg excipient: iron oxide yellow magnesium stearate microcrystalline cellulose purified talc starch tartaric acid - treatment of acute attacks of migraine with or without aura in adults.
codral decongestant
jntl consumer health (new zealand) limited - phenylephrine hydrochloride 10mg; ; - tablet - 10 mg - active: phenylephrine hydrochloride 10mg excipient: colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry brown 85f66607 pregelatinised maize starch stearic acid water
coldrex pe phenylephrine cold & flu plus
haleon new zealand ulc - caffeine 25mg; ; paracetamol 500mg; ; ; ; phenylephrine hydrochloride 5mg; ; - film coated tablet - active: caffeine 25mg paracetamol 500mg phenylephrine hydrochloride 5mg excipient: hypromellose mastercote fa1202 macrogol 400 maize starch microcrystalline cellulose potassium sorbate povidone purified talc sodium laurilsulfate starch stearic acid sunset yellow fcf